Frontlight ResearchEarly access
CompletedNo phase
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
Key facts
- Who runs it
- University of Strathclyde
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 35 people enrolled
- Started
- 23 Mar 2023
- Ended
- 23 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Cognitive behavioural therapy for insomnia
- Record updated
- 12 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Diagnosed with breast cancer
- Aged 18 or over
- Currently prescribed endocrine therapy medication
- Experience symptoms of insomnia
- Self-reported nonadherent to ET medication (e.g. forgetting to take, or deliberately taking a break from medication)
- Proficient in English language
- Access to videoconferencing
Who cannot take part
- Received CBT-I within past 12 months
- Received chemotherapy or radiotherapy within past 4 weeks
- Undertaking shift work (i.e., irregular or night shifts)
- Pregnancy or breastfeeding
- Other unstable physical or mental health problem (including substance misuse)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to investigate the impact of cognitive behavioural therapy for insomnia on adherence to endocrine therapy medication in breast cancer survivors.
The 2 groups in the trial
- Cognitive behavioural therapy for insomniaTreatment being tested
Following randomisation, participants in the intervention group will receive the CBT-I intervention, delivered over 4 weeks.
- Waitlist controlNo study treatment, for comparison
Participants in the waitlist condition will complete all measures at the same timepoints as the intervention group. They will receive the CBT-I intervention after completing the 12-week follow-up assessment. This will then be used as a baseline measure for these participants to compare to their post-intervention and follow-up after receiving the treatment.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence: a Mixed Methods Pilot Study
- Publications
- Cognitive behavioural therapy for insomnia in people with cancer.The Cochrane database of systematic reviews, 2025
- Record updated
- 12 December 2025